Assessment of post-radiotherapy salivary glands by Cheng, SCH et al.
REVIEW ARTICLE
Assessment of post-radiotherapy salivary glands
1S C H CHENG, BSc, 1V W C WU, PhD, 2D L W KWONG, MD and 1M T C YING, PhD
1Department of Health Technology and Informatics, The Hong Kong Polytechnic University, Hunghom, Kowloon, Hong
Kong SAR, China, and 2Department of Clinical Oncology, Queen Mary Hospital, The University of Hong Kong, Pokfulam,
Hong Kong SAR, China
ABSTRACT. Salivary glands are usually irradiated during radiotherapy for head and
neck cancers, which can lead to radiation-induced damage. Radiation-induced
xerostomia (oral dryness) is the most common post-radiotherapy complication for head
and neck cancer patients and can reduce the patient’s quality of life. Accurate and
efficient salivary gland assessment methods provide a better understanding of the
cause and degree of xerostomia, and may help in patient management. At present,
there are different methods for the assessment of salivary gland hypofunction;
however, none of them are considered to be standard procedure. This article reviews
the value of common methods in the assessment of post-radiotherapy salivary glands.
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Major salivary glands are situated in the lateral facial
and submandibular regions where they are commonly
included in or close to the target volume in radiotherapy
of head and neck cancers. Parotid glands are commonly
irradiated with high-radiation doses in two-dimensional
(2D) radiotherapy (conventional radiotherapy) for some
head and neck cancers like nasopharyngeal carcinoma
(NPC) because they are usually in close proximity to, or
within, the radiation field. High-radiation dose can
damage salivary glands and lead to xerostomia (oral
dryness owing to reduced salivary secretion from the
impaired salivary glands). Saliva is produced by acinar
cells, drained to the excretory duct though ductal cells
and finally secreted into the oral cavity [1]. Saliva is
mainly composed of water (99.5%) and the remaining
0.5% includes amylase, inorganic salts, mucin and bicar-
bonate [2]. It is important to normal daily life because
saliva is responsible for moistening and softening food
during ingestion, protecting oral mucosa and teeth, and
breaking down starch using amylase. Xerostomia could
seriously impair health-related quality of life and even
the social activities of long-term survivors following
head and neck radiotherapy [3–5]. This is because xeros-
tomia can lead to alterations in speech and taste, mal-
nutrition and difficulty in mastication and deglutition
[4, 6, 7]. Oral mucosal dryness can also change the oral
pH level and predispose patients to mucosal ulcerations,
fissures, dental caries and oral infection [6, 8, 9].
Clinically, fractionated doses of 50–70 Gy are pre-
scribed over 5–7 weeks (i.e. 2 Gy per day for 5 successive
days per week) for common head and neck cancers [10].
However, Eisbruch et al [11] reported that a mean dose of
26 Gy or above to the parotid gland shows significant
decrease or immeasurable salivary flow upon stimulation.
One must note that radiation-induced xerostomia is an
irreversible complication for the parotid gland which has
received radiation with a mean dose of 26 Gy or above
[11]. The study suggested that a mean dose of 26 Gywas a
threshold dose for stimulated parotid glands. Other
studies have shown different thresholds of radiation dose
for the parotid gland, ranging from 20 Gy to 40 Gy [12].
However, some studies suggested that irreversible xer-
ostomia could occur with a mean dose of over 60 Gy
[10, 13]. This discrepancy in different threshold mean
doses might be due to different methodologies used in
these studies, such as different radiotherapy techniques,
treatment protocols and methods in assessing salivary
function. Although reduced risk of xerostomia with the
use of intensity modulated radiotherapy (IMRT) has been
reported, IMRT could not always achieve the suggested
mean threshold dose for parotid glands because extensive
tumours situated close to the parotid glands in advanced
diseases inevitably deliver a high-dose to the glands [12,
14–16]. Kwong et al [17] reported that themean dose to the
parotid glands could be as high as 32.0–46.1 Gy for early
stage NPC patients treated with IMRT. Eneroth et al [18]
found that radiation as low as 2 to 3 doses of 2 Gy could
cause radiation-induced xerostomia. It has also been
found that a significant decrease in salivary secretion
could appear in the first week of radiotherapy [19]. Hence,
head and neck cancer patients treated with radiothe-
rapy could develop different degrees of xerostomia. To
accurately assess post-radiotherapy changes of salivary
glands or xerostomia, different assessment methods
have been reported in the literature. Improvement in the
assessment of xerostomia or salivary gland function may
allow more accurate evaluation of the dose conformity
to the target and the normal structure sparing capability
of advancing radiotherapy technologies in the head
and neck. Accurate assessment of salivary gland mor-
phological and functional changes after radiotherapy
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may also help to better understand the mechanism of
post-radiotherapy xerostomia, which in turn aids the
investigation of methods to relieve symptoms of xerosto-
mia and improve the quality of life of the patient. It is also
important to identify the post-radiotherapy changes of the
salivary glands and differentiate these from other salivary
gland diseases to ensure accurate diagnosis and appro-
priate disease management of this group of patients.
Although more conformal radiotherapy techniques such
as IMRT and three-dimensional conformal radiotherapy
are replacing conventional radiotherapy for better treat-
ment outcomes of head and neck cancers, it is still
necessary to prove the worthiness of the new techniques
for better disease control and lower risk of complications
including post-radiotherapy salivary gland impairment.
Currently there are various methods for the assessment
of post-radiotherapy salivary glands and radiation-
induced xerostomia, which include histological evalua-
tion, sialometry, MRI, ultrasonography, scintigraphy, CT
and questionnaires. This article reviews the value of these
methods in assessing post-radiotherapy changes in
salivary glands.
Anatomy of salivary glands
In humans there are three pairs of major salivary
glands: the parotid, submandibular and sublingual
glands, as well as numerous minor salivary glands
scattered thoughout the oral cavity.
Parotid gland
The parotid gland is the largest salivary gland located
in the retromandibular fossa (Figure 1). It is composed of
serous acinar cells, which produce serous saliva, mainly
water in content. The imaginary plane formed by the
facial nerve divides the parotid gland into superficial
and deep lobes. The main salivary duct of the parotid
gland is Stensen’s duct, which drains saliva at the upper
second molar tooth level. The parotid gland mainly
secretes saliva in stimulated conditions like chewing,
when it secretes up to 60% of total saliva.
Submandibular gland
The submandibular gland is the second largest
salivary gland located under the floor of the oral cavity
(Figure 1). It is composed of both serous and mucous
acinar cells, which produce thicker and more viscous
saliva. Its main salivary duct is Wharton’s duct, which
drains saliva near the lingual frenula. The submandib-
ular gland mainly secretes saliva in non-stimulated
conditions, producing up to 90% of total salivary output
during the resting state, but contributes only 20–40% of
total saliva in stimulated conditions.
Sublingual gland
The sublingual gland is the smallest among the three
pairs of major salivary glands, which are located in the
floor of the oral cavity and medial to mandible. Similar
to the submandibular gland, the sublingual gland is
composed of both serous and mucous acinar cells, which
produce 2–5% of the total saliva upon stimulation. The
intraglandular ducts of sublingual glands may either
drain into the Wharton’s duct or empty into the floor of
the oral cavity directly.
Histological evaluation
Histological evaluation can assess post-radiotherapy
changes of the salivary glands because functional change
is closely related to histological change [20]. In animal
studies, it has been found that normal parotid glandswere
characterised by homogeneous pure serous acinar cells
with densely packed translucent granules and branching
intercalated ducts [6, 20, 21]. The densely packed acini and
the intercalated ducts were surrounded by myoepithelial
cells [21]. Acini were well differentiated from the in-
terlobular excretory ducts and the striated ducts [21]. On
the other hand, a normal submandibular gland consisted
of both mucous and serous acinar cells and they were
slightly vacuolated [20].
Radfar et al [20] investigated the histological changes
in salivary glands of Hanford minipigs (a small-sized pig
that is a common animal model used to examine post-
radiotherapy salivary gland damage) following a frac-
tionated irradiation scheme of 70 Gy, which was
commonly prescribed in human head and neck cancer
radiotherapy. They found that both irradiated parotid
and submandibular glands were characterised by par-
enchymal loss, acinar atrophy and interstitial fibrosis,
duct proliferation, dilated intercalated and striated duct.
Figure 1. Schematic diagram shows the relative position of
parotid gland (P) and submandibular gland (S) in the head
and neck region. The parotid gland is located in the retroman-
dibular fossa while the submandibular gland is located under
the mandible and in the floor of the oral cavity.
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Loss of secretory granules in acinar cells and infiltration
of inflammatory cells like lymphocytes and plasma cells
were also found. However, acinar destruction and
degranulation were more obvious in submandibular
glands, suggesting that histological change in subman-
dibular glands was more prominent than that in parotid
glands. Prince et al [22] performed a similar study on
monkeys with 50–55 Gy irradiation, and found similar
histological changes in post-radiotherapy parotid and
submandibular glands. In addition, they also found that
the size of parotid and submandibular glands was
reduced after irradiation. However, owing to size
reduction of the salivary glands, they argued that there
should be an increase in the number of ducts per unit
volume in each gland rather than duct proliferation as
Radfar et al [23] reported. Moreover, Henriksson et al
[21] found mast cells and hyaluronic acid infiltration in
irradiated salivary glands of rats, and they believed that
the presence of mast cells and hyaluronic acid might be
the key elements in activating fibrosis in glands after
radiotherapy.
Grehn et al [24] performed an animal study and
reported that the loss of acini in parotid glands was dose-
dependent. With a radiation dose of 30 Gy, there was a
slight decrease in acinar cells from 75.2% in the non-
irradiated glands to 69.8% in the irradiated glands.
However, with 40 Gy a more significant decrease in
acinar cells from 77.3% in non-irradiated glands to 31.9%
in irradiated glands was found. Compared with 30 Gy, a
radiation dose of 40 Gy induced over 50% reduction in
parotid acinar density.
Histology can provide information about the histolo-
gical variation of post-radiotherapy salivary glands.
However, the accuracy of histological findings could
be influenced by ageing. Ageing causes a loss of acinar
cells, for example around 30% of acinar tissue are
lost between 20 and 90 years of age [25]. Scott [26]
reported that uniform and densely packed parenchymal
tissue of submandibular glands in young people are
replaced by loosely fibroadipose tissue with advancing
age.
Although the value of histological examination in
assessing post-radiation salivary glands has been
reported in animal studies, histological evaluation of
salivary glands has not yet been established in clinical
practice for humans. This is because xerostomia is not a
life-threatening condition, and the conduction of the risk-
bearing gland biopsy may not be justified for routine
clinical practice. Biopsy is an invasive procedure and it
may cause complications such as infection, poor wound
healing and fistula formation [27]. Hence, safer or non-
invasive assessment methods such as salivary flow mea-
surement or medical imaging are commonly employed
in the clinical assessment of xerostomia. Nevertheless,
histological studies based on animal models have pro-
vided an invaluable insight in predicting the radiation
response or post-radiotherapy changes of salivary glands
in the human population.
Sialometry
Sialometry (salivary output measurement) has been
widely used in assessing salivary gland function. It
directly measures the function of salivary glands, and
can be classified into the whole mouth salivary output
measurement and selective salivary gland output mea-
surement. Both methods involve the collection of saliva
over a period of time (usually for at least 5 min), and the
saliva volume and the salivary flow rate (usually
expressed as ml min–1) are determined [6]. In sialometry,
both unstimulated and stimulated salivary outputs are
measured in order to assess salivary gland function at
rest and upon stimulation, such as eating [6].
Whole mouth salivary output measurement can be
simply achieved by drainage, spitting or weighing cotton
wool balls soaked with saliva in the mouth [6]. The
procedure is fast, easily performed and inexpensive;
however, it cannot evaluate the function of the indivi-
dual salivary gland. Parotid saliva collection can be done
by catheterisation of the Stensen’s duct or using a suction
cup such as Lashley cup and Carlson-Crittenden cup
attached to the buccal mucosa surrounding to the duct
orifice [1, 6, 11, 28]. Submandibular saliva can be
collected by gentle suction at the Wharton’s duct orifice
of the submandibular gland using a micropipette [25, 29].
However, submandibular secretion is actually the com-
bination of saliva from the submandibular gland and
sublingual gland as sublingual saliva also drains into
Wharton’s duct [28, 30, 31]. Therefore, evaluation of
submandibular secretion and function by this method
should be performed with caution.
Previous studies have used sialometry in the investi-
gation of post-radiotherapy changes of salivary glands.
Eisbruch et al [11] found that parotid glands receiving a
mean dose higher than 24 Gy and 26 Gy showed no
measurable salivary flow and did not recover 12 months
after completion of radiotherapy. Hence, 24 Gy and
26 Gy were the respective threshold doses of unstimu-
lated and stimulated salivary flow. In addition, Eisbruch
et al [28] studied 84 head and neck cancer patients who
received conformal radiotherapy and IMRT thoughout a
2 year post-radiotherapy follow-up, and both stimulated
and unstimulated parotid salivary flows were investi-
gated. They demonstrated that in the bilateral neck
irradiation group, the salivary flow rate of contralateral
parotid glands receiving a mean dose of 21.9 Gy
decreased in the early post-radiotherapy period but
increased continually afterward and nearly returned to
the pre-radiotherapy level after 12 months. The contra-
lateral parotid glands in the unilateral neck irradiation
group receiving relatively lower doses (mean dose,
4.1 Gy) showed continuous salivary flow improvement
during the second year after radiotherapy and even
higher than the pre-radiotherapy level, indicating a
compensatory mechanism [1, 28]. However, in both
bilateral and unilateral neck irradiation groups, no
salivary flow could be detected in the ipsilateral parotid
glands, which received a mean dose higher than 30 Gy
[28]. Submandibular glands in the unilateral neck
irradiation group demonstrated retention of about 50%
of the pre-radiotherapy salivary flow in the first 3
months after radiotherapy, but the flow rate increased
continually to the pre-radiotherapy level after 1 year [28].
The authors only measured the total output of both
submandibular glands, but the contralateral glands
received a much lower mean dose compared with the
ipsilateral glands (14.7 Gy vs 51.4 Gy). Therefore, they
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believed that the salivary output was mainly contributed
by the contralateral glands. In the bilateral neck irradia-
tion group, the salivary flow rates of submandibular
glands remained very low in most patients, in which
ipsilateral and contralateral glands received mean doses
of 66.9 Gy and 57.6 Gy, respectively [28].
Pow et al [32] used sialometry to study the sparing of
salivary gland in IMRT for NPC. They found that both
stimulated parotid and whole mouth salivary flow were
higher in IMRT compared with 2D radiotherapy at 2, 6
and 12 months after radiotherapy. Also, the recovery of
salivary flow was only noted in patients receiving IMRT
but not in the 2D radiotherapy group.
Although sialometry can directly measure the salivary
gland function, there are limitations in the evaluation of
post-radiotherapy salivary functional change. Low
reproducibility of sialometry may lead to an inconsistent
result in the assessment [6]. Ageing may also be a factor
leading to the decrease in salivary flow rate, which
affects the accuracy of post-radiotherapy salivary gland
assessment [25, 30, 33].
Magnetic resonance imaging
MRI is a useful imaging modality for follow-up of
head and neck cancer patients treated with high-dose
radiotherapy [27]. MRI has excellent spatial resolution,
and it is superior to CT in delineating soft-tissue
structures. Moreover, it does not involve ionising
radiation and allows visualisation of deeply situated
tissues, such as the deep lobe of the parotid gland [34].
Nomayr et al [35] evaluated the appearances of
radiation-induced changes in normal cervical structures
including salivary glands using MRI. They found that
volume reduction in the parotid glands occurred after
radiotherapy of 60–70 Gy, and the hyperintense signal
was detected in 22% of post-radiotherapy parotid glands,
and 31% of post-radiotherapy submandibular glands in
T2 weighted (T2W) images. In follow-up examinations,
the signal intensity of the glands decreased in T2W
images but the gland volume continually reduced [35].
Volume reduction and increased signal intensity in
salivary glands after radiotherapy were also documented
in other studies using MRI for post-radiotherapy
evaluation [2, 36]. Increased signal intensity in T2W
images suggested the presence of oedema in the glands
owing to the damage of blood and lymph vessels and
resulted in reduced lymph transport with accumulation
of interstitial fluid [35, 37].
Nomayr et al [35] found that there was a volume
reduction of parotid glands in all patients with primary
neck tumours after radiotherapy, and such volume
reduction might be due to the loss of acinar cells. It is
believed that reduced gland parenchyma is mainly due
to serous acinar cell loss. A larger extent of parenchyma
loss occurs in parotid glands compared with subman-
dibular glands upon irradiation because parotid glands
constitute more serous acini [35]. Parotid glands are
therefore believed to be more radiosensitive than
submandibular glands. However, the difference in the
radiosensitivity of parotid and submandibular glands is
still controversial. Some studies report the radiosensitiv-
ity in parotid and submandibular glands should be
similar as they are equally vulnerable to radiotherapy
[5, 15, 16].
Apart from conventional MRI, a more advanced MRI
technique called MR sialography is becoming popular in
the clinical assessment of radiation-induced changes
in salivary glands. MR sialography uses heavily T2W
sequences to show salivary ducts, and saliva appears as a
hyperintense signal while the surrounding salivary
gland tissues appear hypointense [2, 38]. Unlike conven-
tional X-ray sialography, MR sialography does not
involve any ionising radiation and cannulation of the
salivary ducts, and does not require the introduction of
contrast medium, which avoids the uncomfortable
feeling during the procedure, radiation risk and possible
allergy. Astreinidou et al [38] showed that MR sialo-
graphy could provide high-quality three-dimensional
images of both parotid and submandibular ductal
architectures with high reproducibility. They suggested
that MR sialography could be used in follow-up
examinations to detect the location of potential radia-
tion-induced changes in salivary ducts in post-radio-
therapy patients. Astreinidou et al [1] also found that
there was no significant change in the visibility of the
salivary ducts in the post-radiotherapy compared with
the pre-radiotherapy stage in a low-dose level of below
20 Gy. However, reduced visibility of the ducts occurred
in the salivary glands that received more than 20 Gy, and
increased visibility occurred 6 months post-radiotherapy
compared with 6 weeks post-radiotherapy, indicating
that the gland had a recovery mechanism [1]. Wada et al
[36] also noted the poor visualisation of the intragland-
ular ducts (main ducts and branches) in stimulated
post-radiotherapy parotid and submandibular glands,
indicating radiation-induced injury of the glands. It has
been reported that the poor visualisation of small
intraparotid ducts on MRI after radiotherapy may be
due to the increased signal intensity in post-radiotherapy
salivary gland tissues or damage of the ducts [1].
Although MRI is capable of showing post-radio-
therapy morphological changes in salivary glands and
salivary ducts, it has a number of limitations which have
restricted its wide clinical application. MR sialography is
not effective in detecting or visualising small branches of
the salivary ducts [31]. Compared with other imaging
modalities, MRI is relatively expensive and more
susceptible to motion artefacts owing to its long image
acquisition time [34]. Also, MRI is not suitable for
claustrophobic patients or patients with metallic im-
plants such as pacemakers, bullets, non-MRI compatible
surgical clips and other ferromagnetic implants [31].
Ultrasonography
Ultrasonography is widely used in cancer imaging and
screening as it is safe, non-invasive, inexpensive, widely
available and carries no radiation hazard [39]. It is useful
in delineating superficial soft-tissue structures including
those in head and neck regions like the thyroid gland,
lymph nodes and salivary glands. Although it is
commonly used in the assessment of salivary gland
diseases like neoplasms, Sjogren’s syndrome, sialadenitis
and sialolothiasis, there is scant information in the lite-
rature about ultrasound evaluation of radiation-induced
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xerostomia or post-radiotherapy changes in the salivary
glands [40].
Ultrasonography allows the visualisation of the whole
submandibular gland, sublingual gland and the super-
ficial lobe of the parotid gland. However, the deep lobe
of the parotid gland cannot be assessed by ultrasound
because it is obscured by the acoustic shadow of the
mandibular ramus [41–43]. In ultrasonography, a normal
parotid gland appears as a homogenous speckle pattern
structure [42, 44]. The parotid gland is markedly or
slightly hyperechoic compared with the adjacent muscle
(Figure 2), and echogenicity is determined by the
amount of fatty glandular tissue deposited in the gland
[42, 45]. Normal intraparotid lymph nodes are usually
observed at the pre-auricle level or at the tail of the
gland, which is demonstrated as hypoechoic oval
structures with hyperechoic central hilus [45]. Normal
intraglandular ducts are rarely visualised but they may
appear as slightly echogenic linear structures (Figure 3)
[43, 45].
A normal submandibular gland is shown on ultra-
sonographs as a triangular structure in the transverse
scan plane [43]. Similar to the parotid glands, the normal
submandibular gland appears as a homogeneous struc-
ture with markedly or slightly hyperechoic compared
with the adjacent muscle (Figure 4) [41, 42]. The normal
non-dilated intraglandular ducts of the submandibular
gland are rarely seen on ultrasonographs [43].
To the best of our knowledge, there is only one study
that documented the post-radiotherapy changes of
salivary gland on ultrasonographs. Ying et al [40] used
high-resolution ultrasound to compare the sonographic
appearances of normal and post-radiotherapy parotid
glands. They found that greyscale ultrasound could
be used to assess the size, echogenicity and internal
architecture of the parotid glands. The post-radiotherapy
parotid glands were described as a heterogeneous
structure, hypo- or isoechoic relative to adjacent muscles,
with multiple hyperechoic lines or spots and hypoechoic
areas (Figure 5). Slightly higher conspicuity of intrapar-
otid ducts was noted in post-radiotherapy parotid glands
compared with the normal group. The heterogeneous
appearance of the post-radiotherapy glands might be
due to the patches of inflammatory infiltrate appearing
as multiple hypoechoic areas, while the presence of the
hyperechoic lines or spots might reflect fibrosis [40].
Fibrosis was characterised with hyperechoic lines of
irregular course and thickness but not parallel to each
other, in contrast to the intraparotid ducts which were
demonstrated as hyperechoic lines with regular course
and thickness and parallel to each other [40]. Higher
conspicuity of intraparotid ducts in the post-radio-
therapy parotid glands might be due to fibrosis or
proliferation of the ducts, which provided higher
reflective interfaces for ultrasound beam and thus
increased ductal echogenicity [40]. In Doppler ultra-
sound, the authors found that the mean peak systolic
velocity (PSV), resistive index (RI) and pulsatility index
(PI) of normal parotid glands were significantly higher
than that of post-radiotherapy parotid glands [40]. The
relatively lower vascular resistance and PSV in post-
radiotherapy parotid glands might be due to the lower
compression pressure on the vessels by the reduced
number of surrounding acinar cells and granules [40].
Although this study documented the sonographic
appearances of the post-radiotherapy parotid glands,
Figure 2. Sonogram shows a transverse scan of a normal
parotid gland (arrowheads), which is hyperechoic compared
with the adjacent masseter muscle (arrows).
Figure 3. Sonogram shows a longitudinal scan of a normal
parotid gland with homogeneous echotexture. The intra-
glandular ducts (arrows) are marginally seen.
Figure 4. Sonogram shows a transverse scan of a normal
submandibular gland (arrowheads) with homogeneous
echotexture. The gland is hyperechoic compared with the
adjacent mylohyoid muscle (black arrows) and the intra-
glandular ducts (white arrows) are marginally seen.
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the sample size of the study was small (n510). More-
over, the study focused on the assessment of the
parotid glands in NPC patients treated with conven-
tional radiotherapy.
There are few limitations of using ultrasonography
in the assessment of post-radiotherapy changes in the
salivary glands. The reported sonographic appearances of
the parotid gland in Sjogren’s syndrome were similar to
those observed in the post-radiotherapy parotid changes,
including heterogeneous echotexture, multiple hypoe-
choic areas and multiple hyperechoic lines or spots
[46–48]. Such similarity in sonographic appearances could
be confusing when differentiating post-radiotherapy
changes with Sjogren’s syndrome, leading to inaccurate
diagnosis. Ultrasound can not evaluate the deep lobe of
the parotid gland as it is obscured by the acoustic shadow
of the ramus of mandible [43, 42]. Therefore, the size of
the parotid gland cannot be fully evaluated. Operator
dependency is also a limitation of ultrasonography [39].
Scintigraphy
Salivary gland scintigraphy has been used in the
assessment of salivary gland function including the post-
radiotherapy salivary functional change for decades. It
makes use of the absorption and excretion properties of
radioisotopes such as 99mTc at the salivary glands for
functional assessment [2, 30]. It has been found that
99mTc is readily trapped and secreted in the ductal
epithelium of salivary glands and excreted in the saliva,
which allows salivary gland scintigraphy to be per-
formed and provides quantitative information on the
glandular function [49, 50]. Apart from minimal inva-
siveness, scintigraphy has a low radiation dose, good
patient tolerance, no interference with the normal
physiology of the salivary glands and ready availability
of 99mTc, which make it valuable to salivary functional
studies [30, 50]. Scintigraphy provides results for seve-
ral parameters in salivary functional assessment such
as time-activity curve analysis, visual interpretation,
salivary target to background ratio and salivary excretion
fraction (SEF) [51]. Although parameters help the
assessment of different functions of the glands, there is
a lack of standardisation in the use of certain parameters,
such as SEF, for physicians interpreting salivary scinti-
grams. Nevertheless, SEF is commonly used to assess
radiation-induced xerostomia or other salivary gland
diseases [30, 49, 52, 53].
Liem et al [49] found that many post-radiotherapy
salivary glands showed impaired saliva excretion with a
large amount of radiopharmaceutical (i.e. 99mTc) retained
in the salivary glands, and there was no decline in time-
activity curves even though the glands were stimulated.
As damaged salivary glands fail to excrete saliva into the
oral cavity, the radiopharmaceutical cannot be removed
by saliva from the gland and it accumulates and is
retained within the gland. They also found that there was
a dose–response relationship of both the parotid and
submandibular glands, which demonstrated that higher
radiation doses cause greater reduction in SEF of the
salivary glands. A rapid decrease in SEF could occur in
salivary glands receiving a radiation dose of 30–70 Gy as
early as 1 month after radiotherapy, but SEF can remain
unchanged in the glands receiving radiation of less than
24 Gy. A persistent decrease in SEF for 6 and 12 months
after radiotherapy was seen in both parotid and subman-
dibular glands receiving more than 30 Gy of radiation
[49]. Kohn et al [30] also demonstrated a positive cor-
relation between the salivary flow rate and the scintiscan
rating (the summary score of different salivary gland
scintigram parameters including initial uptake of the tra-
cer, appearance of unstimulated radionuclide in the oral
cavity, radiopharmaceutical concentration in the glands
and response to stimulation) of salivary gland scintigra-
phy in xerostomia patients.
Although salivary gland scintigraphy could reflect the
functional change of salivary glands after radiotherapy,
its spatial resolution was low and not suitable for the
evaluation of morphological change of the glands [30].
Moreover, scintigraphy may not be sensitive enough in
detecting slight changes in salivary gland excretion [54].
Hermann et al [51] found that SEF could only distinguish
Sjogren’s syndrome or radiation damage from normal
salivary glands but not from each other, which reflected
the poor specificity of scintigraphy in identifying
radiation-induced injury in salivary glands. The com-
plexity of the procedure including a range of patient
preparation and co-operation, such as fasting and post-
imaging radiation management, and the involvement of
ionising radiation restrict the use of scintigraphy in
routine clinical assessment of salivary gland function.
Computed tomography
CT has been widely used in head and neck cancer
imaging. However, there is scant information regarding
the application of CT in post-radiotherapy salivary gland
evaluation. CT has been proven to be an effective
imaging method in the assessment of salivary glands,
with nearly 100% sensitivity in detecting salivary gland
lesions [34, 35]. A normal parotid gland is a fatty
glandular tissue encapsulated by a dense capsule, which
is shown as a radiolucent structure in CT compared with
Figure 5. Sonogram shows a longitudinal scan of a parotid
gland in a patient treated with conventional radiotherapy.
There are multiple hypoechoic areas (arrows) within the
gland, and the intraglandular ducts (arrowheads) are
obviously seen.
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the surrounding muscles [55, 56]. In CT, parotid ducts
are hardly seen. However, the introduction of iodinated
contrast medium increases the sensitivity in the detection
of parotid ducts [55, 57]. CT can demonstrate the entire
physical volume of the parotid glands.
In CT, the superficial portion of a normal submandib-
ular gland is usually shown as a globular soft-tissue
structure superior and lateral to the hyoid bone on CT
images [55]. It is more radio-opaque than parotid gland
but with a similar opacity to the adjacent muscle [55, 56].
The deep portion of the gland and the intraglandular
ducts are well visualised on CT scans [55].
Bronstein et al [56] reported an increased image
density in post-radiotherapy salivary glands on con-
trast-enhanced CT scans (Figure 6). They found that
increased image density was associated with a high dose
of irradiation to the glands (.45 Gy). Both parotid and
submandibular glands showed a similar degree of
increased image density after radiotherapy, and the
increased image density might be due to the contrast
medium stored in the expanded extracellular space
resulting in the loss of acinar cells after radiotherapy [56].
Since CT generates cross-sectional images of the region
of interest, localisation and volume determination of
organs and lesion are possible. Previous studies have
found that there was a decrease in parotid gland volume
with a rate of 0.6–0.7% volume loss per day during
radiotherapy for head and neck cancers, and the median
parotid volume loss at the end of treatment was 21.3%
[58] or 28.1% [59]. Apart from volume reduction, medial
shift of parotid gland with median values of 5.26 mm
[58] and 3.1 mm [59] after radiotherapy was also noted.
The reduced volume and positional change of salivary
glands are important for physicians to determine the
post-radiotherapy changes in salivary glands and treat-
ment planning since the change in volume or position
may lead to a higher dose received by the glands than
expected in the initial treatment planning, especially in
IMRT [58]. Hence, replanning within the treatment
course may be necessary to ensure the optimal treatment
outcomes.
There are some limitations in using CT to assess post-
radiotherapy salivary gland changes. Increased image
density of salivary glands occurs in radiation doses
higher than 45 Gy, but salivary gland dysfunction or
radiation-induced xerostomia can happen with a radia-
tion dose below 45 Gy [12, 19, 60]. Also, increased image
density was noted in salivary gland tumours and hence
image density variations of the glands might not be an
accurate indicator to show post-radiation changes [56].
Moreover, a decrease in CT number of salivary gland
owing to ageing and increase in adipose tissue [61], and
spray artefact from dental filling, would also limit the
use of CT on salivary gland diagnosis [62]. CT involves
ionising radiation, and iodinated contrast medium is
usually required for the examination, which increases
the risk of radiation and risk of allergic reaction towards
the contrast agents. The use of contrast medium in CT is
also contraindicated to patients with poor renal function.
Xerostomia questionnaire
A xerostomia questionnaire is a useful tool in assessing
the quality of life for patients with radiation-induced
xerostomia. Some questionnaires have been validated to
(a) (b)
Figure 6. (a) Axial CT scan of skull in a nasopharyngeal carcinoma patient before radiotherapy. The image density of the parotid
gland (P) is about the same as the adjacent masseter muscle (M). (b) Axial CT scan of a skull in the same patient after
radiotherapy. There is an increased image density of the parotid gland (P) when compared with the pre-radiotherapy scan. The
image density of the parotid gland is greater than that of the adjacent masseter muscle (M).
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evaluate the quality of life of post-radiotherapy xeros-
tomic patients by assessing the ease or difficulty of
different oral activities in their daily life [28, 63].
To quantify the quality of life of patients with xerosto-
mia, a visual analogue scale or an 11-point ordinal Likert
scale is usually used to evaluate the oral dryness or oral
discomfort of the patient [7, 28, 63]. The summation of the
score of each item (xerostomia score) in the questionnaire
is used to indicate the severity of xerostomia [28].
Eisbruch et al [11] showed that the xerostomia score
obtained from the patients after head and neck radio-
therapy was significantly higher than the score obtained
from the same group of patients before radiotherapy.
This demonstrated that the xerostomia questionnaire
could detect oral discomfort owing to reduced salivary
secretion after radiotherapy. In the follow-up examina-
tions significant decreases in xerostomia scores were
found in patients indicating improvement in oral
dryness and discomfort. Eisbruch et al [4] reported a
lower xerostomia score (less oral dryness) in patients
receiving radiotherapy with parotid glands sparing than
those treated with conventional radiotherapy.
Similar to other assessment methods, there are limita-
tions of using questionnaires in the assessment of
xerostomia. The assessment method is subjective and
does not provide quantitative analysis of the function of
the salivary glands. There was a weak correlation
between xerostomia score and the salivary flow
[19, 28, 49]. This weak correlation may be due to the
large variation in normal salivary flow rate and the
discrepancy between mucosa hydration status and
salivary output [28]. Moreover, oral sensory change or
alteration in the perception of oral dryness in the
mucosal tissue may occur after radiotherapy [29].
Conclusions
A variety of methods are currently available for the
evaluation of radiation-induced xerostomia or salivary
gland changes. Although there is still a lack of a
standardised method for the assessment, morphological
assessment methods (i.e. histological evaluation, CT, MRI
and ultrasonography) and functional assessment meth-
ods (i.e. sialometry, MR sialography and scintigraphy)
can be used together for a more accurate assessment of
post-radiotherapy salivary gland. Nevertheless, more
effort should be made in the improvement of evaluation
of radiation-induced salivary gland changes for better
clinical management of patients treated with head and
neck radiotherapy.
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